Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | -99,00% | -99,00% | -99,97% |
2023 | Sectorupdate: Aandelen gezondheidszorg dalen aan het eind van de middag | MT |
2023 | Top Middag Decliners | MT |
Omzet 2021 | 17,5 mln. 16,43 mln. | Omzet 2022 | 49,72 mln. 46,67 mln. | Marktkapitalisatie | 111 mln. 104 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -64 mln. -60,08 mln. | Nettowinst (verlies) 2022 | -51 mln. -47,88 mln. | EV/omzet 2021 | 5,55 x |
Nettoschuld 2021 | 7,2 mln. 6,76 mln. | Nettoschuld 2022 | 12,95 mln. 12,15 mln. | EV/omzet 2022 | 2,49 x |
K/w-verhouding 2021 |
-1,12
x | K/w-verhouding 2022 |
-1,95
x | Werknemers | 125 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 96,32% |
Recentste transcriptie over RVL Pharmaceuticals plc
1 dag | -99,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sergio Alegre
CMP | Compliance Officer | - | 01-08-16 |
James Schaub
COO | Chief Operating Officer | 42 | 01-01-16 |
Michael Depetris
AUD | Comptroller/Controller/Auditor | - | 18-04-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Cowan
BRD | Director/Board Member | 70 | 01-01-19 |
Alisa Lask
BRD | Director/Board Member | 53 | 10-08-22 |
Michael DeBiasi
BRD | Director/Board Member | 48 | 01-10-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 0,000001 | -99,00% | 14 155 |
17-04-24 | 0,0001 | +9.900,00% | 516 |
11-04-24 | 0,000001 | 0,00% | 100 000 |
uitgestelde koers OTC Markets, 19 april 2024 om 21:51 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-99,97% | 111 | |
-5,99% | 83,66 mld. | |
+2,76% | 40,41 mld. | |
-24,88% | 28,26 mld. | |
+53,61% | 24,53 mld. | |
-8,08% | 16,82 mld. | |
-33,74% | 13,39 mld. | |
-16,63% | 11,75 mld. | |
-11,19% | 11,69 mld. | |
-2,25% | 8,13 mld. |